Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Zhifang Ying"'
Autor:
Yajun Shu, Zhuoqun Sun, Fan Gao, Zhuhang Huang, Xing Meng, Shaomin Chen, Qun Shu, Lianhao Wang, Hengming Zhang, Zhifang Ying, Jikai Zhang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This study aimed to provide evidence for co-administration of the COVID-19 and EV71 vaccines in children aged 3 to 5 years. We conducted a phase 4, open-label, randomized, and controlled study. A total of 520 children were randomly allocated to two g
Externí odkaz:
https://doaj.org/article/626afe12c80541909b20cbb0a2ffecfd
Autor:
Shaomin Chen, Zhifang Ying, Yan Liu, Yuan Li, Yebin Yu, Meilian Huang, Zhuhang Huang, Zhiqiang Ou, Yuyi Liao, Yong Zhang, Guixiu Liu, Weiwei Zhao, Rong Fu, Qiong Shou, Minghuan Zheng, Xueyan Liao, Yingmei Tu, Jon Stek, Jonathan Hartzel, Changgui Li, Jikai Zhang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis open-label, randomized, phase 3 study in China (V260-074; NCT04481191) evaluated the immunogenicity and safety of concomitant and staggered administration of three doses of an oral, live, pentavalent rotavirus vaccine (RV5) and three dos
Externí odkaz:
https://doaj.org/article/0433b9f021254813a1d04914c2993518
Autor:
Lei Ma, Zhifang Ying, Wei Cai, Jianfeng Wang, Jian Zhou, Huijuan Yang, Jingxia Gao, Zhimei Zhao, Jing Liu, Shengjie Ouyang, Shaohui Song, Fei Shen, Ruirui Zhao, Lilan Xu, Xiaohu Dai, Yanan Wu, Weidong Li, Changgui Li, Guoyang Liao
Publikováno v:
EClinicalMedicine, Vol 64, Iss , Pp 102151- (2023)
Summary: Background: In a previous phase 3 clinical trial, we showed that an inactivated poliovirus vaccine derived from the Sabin strain (sIPV) can induce neutralising antibodies against currently circulating and reference wild poliovirus strains. H
Externí odkaz:
https://doaj.org/article/c49a7d2187674c80b3ef8ed9e887b63d
Autor:
Lei Wang, Zhiwei Wu, Zhifang Ying, Minjie Li, Yuansheng Hu, Qun Shu, Jing Li, Huixian Wang, Hengming Zhang, Wenbin Jiao, Lin Wang, Yuliang Zhao, Qiang Gao
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Few countries have approved SARS-CoV-2 booster doses in children and adolescents due to insufficient evidence about the safety and interval vaccination. Here, the authors assess the safety and immunogenicity of a homologous booster dose of CoronaVac
Externí odkaz:
https://doaj.org/article/921d5b11e66d49c1b7dd65a34377be6f
Autor:
Qiongzhou Yin, Yan Zheng, Zhifang Ying, Jingyu Li, Ya Jiang, Wenmei Bao, Youjian Dou, Yi Pu, Jin Lei, Haitao Yang, Ruiju Jiang, Yan Deng, Zhimei Zhao, Jing Pu, Jing Yang, Yadong Li, Min Xu, Wei Cai, Yanchun Che, Li Shi
Publikováno v:
Vaccines, Vol 12, Iss 2, p 217 (2024)
Background: An inactivated poliomyelitis vaccine made from Sabin strains (sIPVs) has widely been used in China since 2015. However, the quantitative data on the instant and persistent inhibition effects of maternal poliovirus antibodies on the immune
Externí odkaz:
https://doaj.org/article/9f0bacde7e3b4faaa5c55e5976696f11
Autor:
Xingxing Li, Jingjing Liu, Wenjuan Li, Qinhua Peng, Miao Li, Zhifang Ying, Zelun Zhang, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Guangzhi Yue, Yue Suo, Jianhui Nie, Weijin Huang, Jia Li, Yuhua Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or 2019-nCoV) variants has been associated with the transmission and pathogenicity of COVID-19. Therefore, exploring the optimal immunisation strategy to improve the
Externí odkaz:
https://doaj.org/article/ed4ce87f1c364ac099e43b924d0726bd
Autor:
Shiyi Chen, Yuping Zhao, Zhiyao Yang, Ying Li, Hongyuan Shi, Ting Zhao, Xiaolei Yang, Jing Li, Guoliang Li, Jianfeng Wang, Zhifang Ying, Jingsi Yang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
In recent years, the Global Polio Eradication Initiative has gradually implemented a global shift in polio immunization programs. Few studies cover polio immunization program impacts on the efficacy of other vaccines. This study investigated whether
Externí odkaz:
https://doaj.org/article/e41e64df539a47278f374b1acf225fbd
Autor:
Zheng Jiang, Guixiu Liu, Liao Guo-yang, Mingbo Sun, Kangwei Xu, Zhifang Ying, Jianfeng Wang, Xuguang Li, Changgui Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 349-357 (2019)
The evaluation of the immunogenicity of Sabin strain based Inactivated Poliovirus Vaccines (sIPV) necessitates the use of wild strains in neutralization assays to assess the potential cross-reactivity of antibodies. The live virus strains including w
Externí odkaz:
https://doaj.org/article/b0b2eef282f54bc0adf97961924363b3
Autor:
Yamin Wang, Qing Xu, Vishali Jeyaseelan, Zhifang Ying, Ondrej Mach, Roland Sutter, Ning Wen, Lance Rodewald, Changgui Li, Jie Wang, Hui Yuan, Zundong Yin, Zijian Feng, Aiqiang Xu, Zhijie An
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 10, Iss , Pp 100133- (2021)
Background: We assessed immunogenicity of three-dose and two-dose immunization schedules with a Sabin-strain inactivated poliovirus vaccine (sIPV) produced by one Chinese vaccine manufacturer. Methods: This was an open label, randomized, controlled t
Externí odkaz:
https://doaj.org/article/b20ec2696b7e4edc9fab603bdfc2535f
Autor:
Yan Zheng, Zhifang Ying, Yanxiang Zou, Taotao Zhu, Dinggu Qian, Weixiao Han, Ya Jiang, Zhiwei Jiang, Xingyan Li, Jianfeng Wang, Jin Lei, Li Xu, Deyu Jiang, Changgui Li, Xiaoqiang Liu
Publikováno v:
Vaccines, Vol 10, Iss 2, p 254 (2022)
Background: The Sabin-strain-based inactivated poliovirus vaccine (sIPV) plays an important role in poliomyelitis eradication in developing countries. As part of the phase III clinical development program, this study aimed to evaluate the safety, imm
Externí odkaz:
https://doaj.org/article/8f03e541be8c4179b419867d0315f6a2